Holen Sie sich die Stockscreener-App
8.57
2.94%
-0.26
Handel nachbörslich:
8.60
0.03
+0.35%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$8.83
Offen:
$8.89
24-Stunden-Volumen:
4.18M
Relative Volume:
0.90
Marktkapitalisierung:
$1.71B
Einnahmen:
$3.68B
Nettoeinkommen (Verlust:
$-627.00M
KGV:
-2.7226
EPS:
-3.1477
Netto-Cashflow:
$104.00M
1W Leistung:
-2.94%
1M Leistung:
-15.48%
6M Leistung:
-29.11%
1J Leistung:
-32.09%
1-Tages-Spanne:
$8.54
$8.93
1-Wochen-Bereich:
$8.32
$8.94
52-Wochen-Spanne:
$8.32
$14.76
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
8.57 | 1.71B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
426.70 | 150.74B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
191.75 | 52.23B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
238.97 | 33.61B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.18 | 31.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
35.96 | 31.55B | 29.14B | 1.07B | 1.05B | 1.1956 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2026-04-15 | Eingeleitet | Citigroup | Sell |
| 2026-02-19 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Underweight |
| 2025-11-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
DENTSPLY SIRONA (NASDAQ:XRAY) Sets New 52-Week LowTime to Sell? - MarketBeat
Dentsply Sirona stock hits 52-week low at 8.38 USD By Investing.com - Investing.com Canada
Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal - Zacks Investment Research
Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal - Yahoo Finance
DENTSPLY SIRONA Inc. (XRAY) Options ChainYahoo Finance - Yahoo! Finance Canada
DENTSPLY SIRONA Inc. (XRAY) Options Chain - Yahoo! Finance Canada
DENTSPLY SIRONA Inc. Obtains Consent Under Revolving Credit Facility And Enters Into Note Purchase Agreement Amendments - www.marketscreener.com
Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
DENTSPLY SIRONA (XRAY) Tests Its Reset Story After Midwest Dental Expansion - Yahoo Finance
Dentsply Sirona expands Midwest Dental deal: what it means for XRAY stock - AD HOC NEWS
Dentsply Sirona stock gets a seventh North American dealer deal - AD HOC NEWS
Dentsply Sirona expands distribution deal with Midwest Dental By Investing.com - Investing.com Canada
Dentsply Sirona expands distribution deal with Midwest Dental - Investing.com India
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement - GlobeNewswire
Dentsply Sirona hits 52-week low as analysts rate Dentsply Sirona stock Hold - AD HOC NEWS
Dentsply Sirona stock hits 52-week low at 8.55 USD - Investing.com
Dentsply Sirona Inc. R (DY2.DU) Q2 FY2026 earnings call transcript - Yahoo Finance
DENTSPLY SIRONA Inc. (XRAY) Stock Forecasts - Yahoo Finance
A director gains 3,323 units payable in stock after his service ends at DENTSPLY SIRONA (XRAY). - Stock Titan
DENTSPLY SIRONA Inc. (XRAY) Stock forecasts - Yahoo Finance UK
DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year LowHere's Why - MarketBeat
ETFs Investing in DENTSPLY SIRONA, Inc. Stocks - TradingView
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Rated "Hold" by Sell-Side Analysts - MarketBeat
Dentsply Sirona's Troubles Are Nothing To Smile About (Downgrade) (NASDAQ:XRAY) - Seeking Alpha
Dentsply Sirona stock hits 52-week low at 9.35 USD By Investing.com - Investing.com Nigeria
Dentsply Sirona stock hits 52-week low at 9.35 USD - Investing.com
DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 1-Year LowTime to Sell? - MarketBeat
DENTSPLY SIRONA (NasdaqGS:XRAY) Stock Forecast & Analyst Predictions - Simply Wall Street
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks - Yahoo Finance
DENTSPLY SIRONA Inc. (XRAY) Stock Forecasts - Yahoo Finance
Bank of America Corp DE Makes New Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (XRAY) Institutional Ownership 2026 $XRAY - MarketBeat
Dentsply Sirona: The Valuation Is Low, But The Turnaround Is Not Proven Yet (NASDAQ:XRAY) - Seeking Alpha
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now - Yahoo Finance
Robbins Geller Rudman & Dowd LLP Announces Pending Class Action Lawsuit in the Dentsply Securities Litigation - marketscreener.com
VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
ETFs Investing in DENTSPLY SIRONA, Inc. Stocks - tradingview.com
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 182,661 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Investor Suit Over Pandemic Woes Lined Up For Trial - Law360
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure - Yahoo Finance
Law firm investigates Dentsply Sirona officers for possible breaches of shareholder duties - Pluang
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders? - The Conway Daily Sun
Legal & General Group Plc Makes New $3.25 Million Investment in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (XRAY) Returns To Profit As Investors Weigh Its Valuation - Yahoo Finance
Dentsply Sirona (XRAY) Stock May Still Trade At A Discount - Yahoo Finance
The Manufacturers Life Insurance Company Takes Position in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Does XRAY’s Profit Recovery and Reaffirmed 2026 Outlook Shift the Dentsply Sirona Thesis? - Yahoo Finance
A live webcast will carry Dentsply Sirona’s Sept. 15 presentation - Stock Titan
Dentsply Sirona (XRAY) Swings Back To Profit While Sales Keep Sliding - Yahoo Finance
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference - GlobeNewswire
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dentsply Sirona Inc-Aktie (XRAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gladden Brian T | Director |
Jun 15 '26 |
Buy |
10.02 |
9,985 |
100,000 |
61,849 |
| MCKEON BRIAN P | Director |
Jun 12 '26 |
Buy |
10.12 |
10,000 |
101,200 |
10,000 |
| Barber Michael J | Director |
Jun 11 '26 |
Buy |
9.88 |
15,175 |
150,005 |
55,943 |
| HOLDEN BETSY D | Director |
Jun 11 '26 |
Buy |
9.88 |
10,086 |
99,692 |
87,528 |
| LUCIER GREGORY T | Director |
Mar 09 '26 |
Buy |
12.45 |
15,000 |
186,675 |
65,000 |
| Forbes James D | Director |
Mar 09 '26 |
Buy |
12.48 |
5,000 |
62,400 |
10,000 |
| LUCIER GREGORY T | Director |
Mar 03 '26 |
Buy |
14.03 |
22,445 |
314,858 |
50,000 |
| LUCIER GREGORY T | Director |
Mar 02 '26 |
Buy |
14.24 |
27,555 |
392,521 |
27,555 |
| LUCIER GREGORY T | DIRECTOR |
Dec 08 '25 |
Proposed Sale |
11.10 |
82,200 |
912,420 |
0 |
| LUCIER GREGORY T | Director |
Dec 08 '25 |
Sale |
11.14 |
82,200 |
915,708 |
0 |
5.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):